T ROWE PRICE GROUP INC (TR1.DE) Stock Fundamental Analysis

FRA:TR1 • US74144T1088

78.92 EUR
-0.02 (-0.03%)
Last: Feb 13, 2026, 07:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to TR1. TR1 was compared to 118 industry peers in the Capital Markets industry. TR1 has an average financial health and profitability rating. TR1 may be a bit undervalued, certainly considering the very reasonable score on growth Finally TR1 also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • TR1 had positive earnings in the past year.
  • In the past year TR1 had a positive cash flow from operations.
  • Each year in the past 5 years TR1 has been profitable.
  • In the past 5 years TR1 always reported a positive cash flow from operatings.
TR1.DE Yearly Net Income VS EBIT VS OCF VS FCFTR1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • TR1's Return On Assets of 14.20% is amongst the best of the industry. TR1 outperforms 94.02% of its industry peers.
  • With a decent Return On Equity value of 18.75%, TR1 is doing good in the industry, outperforming 77.78% of the companies in the same industry.
Industry RankSector Rank
ROA 14.2%
ROE 18.75%
ROIC N/A
ROA(3y)14.53%
ROA(5y)16.13%
ROE(3y)18.95%
ROE(5y)21.47%
ROIC(3y)N/A
ROIC(5y)N/A
TR1.DE Yearly ROA, ROE, ROICTR1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • TR1's Profit Margin of 27.84% is fine compared to the rest of the industry. TR1 outperforms 74.36% of its industry peers.
  • TR1's Profit Margin has declined in the last couple of years.
  • The Operating Margin of TR1 (33.12%) is better than 72.65% of its industry peers.
  • TR1's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 33.12%
PM (TTM) 27.84%
GM N/A
OM growth 3Y-6.39%
OM growth 5Y-5.62%
PM growth 3Y5.88%
PM growth 5Y-5.62%
GM growth 3YN/A
GM growth 5YN/A
TR1.DE Yearly Profit, Operating, Gross MarginsTR1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

5

2. Health

2.1 Basic Checks

  • The number of shares outstanding for TR1 has been reduced compared to 1 year ago.
  • The number of shares outstanding for TR1 has been reduced compared to 5 years ago.
  • There is no outstanding debt for TR1. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TR1.DE Yearly Shares OutstandingTR1.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
TR1.DE Yearly Total Debt VS Total AssetsTR1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.2 Solvency

  • There is no outstanding debt for TR1. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
TR1.DE Yearly LT Debt VS Equity VS FCFTR1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
TR1.DE Yearly Current Assets VS Current LiabilitesTR1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

4

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 4.18% over the past year.
  • Measured over the past 5 years, TR1 shows a small growth in Earnings Per Share. The EPS has been growing by 0.25% on average per year.
  • The Revenue has been growing slightly by 3.12% in the past year.
  • TR1 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.34% yearly.
EPS 1Y (TTM)4.18%
EPS 3Y6.66%
EPS 5Y0.25%
EPS Q2Q%15.09%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y4.08%
Revenue growth 5Y3.34%
Sales Q2Q%6.01%

3.2 Future

  • Based on estimates for the next years, TR1 will show a small growth in Earnings Per Share. The EPS will grow by 5.48% on average per year.
  • Based on estimates for the next years, TR1 will show a small growth in Revenue. The Revenue will grow by 2.06% on average per year.
EPS Next Y7.63%
EPS Next 2Y4.88%
EPS Next 3Y3.45%
EPS Next 5Y5.48%
Revenue Next Year5.37%
Revenue Next 2Y4.24%
Revenue Next 3Y0.62%
Revenue Next 5Y2.06%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TR1.DE Yearly Revenue VS EstimatesTR1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B
TR1.DE Yearly EPS VS EstimatesTR1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10

7

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 9.64, which indicates a very decent valuation of TR1.
  • 87.18% of the companies in the same industry are more expensive than TR1, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of TR1 to the average of the S&P500 Index (26.68), we can say TR1 is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 8.95, the valuation of TR1 can be described as reasonable.
  • 92.31% of the companies in the same industry are more expensive than TR1, based on the Price/Forward Earnings ratio.
  • TR1's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.06.
Industry RankSector Rank
PE 9.64
Fwd PE 8.95
TR1.DE Price Earnings VS Forward Price EarningsTR1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, TR1 is valued cheaper than 88.89% of the companies in the same industry.
  • 88.89% of the companies in the same industry are more expensive than TR1, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.67
EV/EBITDA 6.04
TR1.DE Per share dataTR1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.26
PEG (5Y)38.74
EPS Next 2Y4.88%
EPS Next 3Y3.45%

7

5. Dividend

5.1 Amount

  • TR1 has a Yearly Dividend Yield of 5.58%, which is a nice return.
  • Compared to an average industry Dividend Yield of 3.21, TR1 pays a better dividend. On top of this TR1 pays more dividend than 89.74% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.84, TR1 pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.58%

5.2 History

  • On average, the dividend of TR1 grows each year by 10.37%, which is quite nice.
Dividend Growth(5Y)10.37%
Div Incr Years2
Div Non Decr Years2
TR1.DE Yearly Dividends per shareTR1.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 2 4 6

5.3 Sustainability

  • TR1's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP0%
EPS Next 2Y4.88%
EPS Next 3Y3.45%
TR1.DE Yearly Income VS Free CF VS DividendTR1.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

T ROWE PRICE GROUP INC

FRA:TR1 (2/13/2026, 7:00:00 PM)

78.92

-0.02 (-0.03%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-04
Earnings (Next)04-30
Inst Owners81.71%
Inst Owner ChangeN/A
Ins Owners1.69%
Ins Owner ChangeN/A
Market Cap17.25B
Revenue(TTM)7.31B
Net Income(TTM)2.04B
Analysts49.47
Price Target91.17 (15.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.58%
Yearly Dividend4.28
Dividend Growth(5Y)10.37%
DP0%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.29%
Min EPS beat(2)-3.09%
Max EPS beat(2)9.67%
EPS beat(4)3
Avg EPS beat(4)3.03%
Min EPS beat(4)-3.09%
Max EPS beat(4)9.67%
EPS beat(8)5
Avg EPS beat(8)3.34%
EPS beat(12)9
Avg EPS beat(12)5.61%
EPS beat(16)11
Avg EPS beat(16)2.69%
Revenue beat(2)0
Avg Revenue beat(2)-1.4%
Min Revenue beat(2)-1.67%
Max Revenue beat(2)-1.12%
Revenue beat(4)0
Avg Revenue beat(4)-1.99%
Min Revenue beat(4)-2.98%
Max Revenue beat(4)-1.12%
Revenue beat(8)1
Avg Revenue beat(8)-2.77%
Revenue beat(12)2
Avg Revenue beat(12)-2.09%
Revenue beat(16)3
Avg Revenue beat(16)-2.77%
PT rev (1m)-4.52%
PT rev (3m)-3.41%
EPS NQ rev (1m)-3.4%
EPS NQ rev (3m)-3.15%
EPS NY rev (1m)0.11%
EPS NY rev (3m)0.99%
Revenue NQ rev (1m)-0.62%
Revenue NQ rev (3m)-0.93%
Revenue NY rev (1m)-0.42%
Revenue NY rev (3m)-0.53%
Valuation
Industry RankSector Rank
PE 9.64
Fwd PE 8.95
P/S 2.8
P/FCF 11.67
P/OCF 11.67
P/B 1.88
P/tB 2.58
EV/EBITDA 6.04
EPS(TTM)8.19
EY10.38%
EPS(NY)8.82
Fwd EY11.18%
FCF(TTM)6.76
FCFY8.57%
OCF(TTM)6.76
OCFY8.57%
SpS28.21
BVpS41.88
TBVpS30.63
PEG (NY)1.26
PEG (5Y)38.74
Graham Number87.85
Profitability
Industry RankSector Rank
ROA 14.2%
ROE 18.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 33.12%
PM (TTM) 27.84%
GM N/A
FCFM 23.97%
ROA(3y)14.53%
ROA(5y)16.13%
ROE(3y)18.95%
ROE(5y)21.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-6.39%
OM growth 5Y-5.62%
PM growth 3Y5.88%
PM growth 5Y-5.62%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 61.99%
Profit Quality 86.1%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)66.69%
Profit Quality(5y)89.3%
High Growth Momentum
Growth
EPS 1Y (TTM)4.18%
EPS 3Y6.66%
EPS 5Y0.25%
EPS Q2Q%15.09%
EPS Next Y7.63%
EPS Next 2Y4.88%
EPS Next 3Y3.45%
EPS Next 5Y5.48%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y4.08%
Revenue growth 5Y3.34%
Sales Q2Q%6.01%
Revenue Next Year5.37%
Revenue Next 2Y4.24%
Revenue Next 3Y0.62%
Revenue Next 5Y2.06%
EBIT growth 1Y1.88%
EBIT growth 3Y-2.57%
EBIT growth 5Y-2.47%
EBIT Next Year24.02%
EBIT Next 3Y2.45%
EBIT Next 5Y2.94%
FCF growth 1Y38.92%
FCF growth 3Y-6.16%
FCF growth 5Y0.57%
OCF growth 1Y4.02%
OCF growth 3Y-9.42%
OCF growth 5Y-1.79%

T ROWE PRICE GROUP INC / TR1.DE FAQ

Can you provide the ChartMill fundamental rating for T ROWE PRICE GROUP INC?

ChartMill assigns a fundamental rating of 5 / 10 to TR1.DE.


What is the valuation status of T ROWE PRICE GROUP INC (TR1.DE) stock?

ChartMill assigns a valuation rating of 7 / 10 to T ROWE PRICE GROUP INC (TR1.DE). This can be considered as Undervalued.


Can you provide the profitability details for T ROWE PRICE GROUP INC?

T ROWE PRICE GROUP INC (TR1.DE) has a profitability rating of 4 / 10.


Can you provide the financial health for TR1 stock?

The financial health rating of T ROWE PRICE GROUP INC (TR1.DE) is 5 / 10.


What is the expected EPS growth for T ROWE PRICE GROUP INC (TR1.DE) stock?

The Earnings per Share (EPS) of T ROWE PRICE GROUP INC (TR1.DE) is expected to grow by 7.63% in the next year.